Table 5. MDR E. coli, Salmonella spp. and Pseudomonas spp. isolated from houseflies.
|
Antimicrobial compound |
Number of MDR isolates (%) |
|
E. coli (n=10) |
|
|
E, B, VA |
1(10%) |
|
VA, Met, AMX |
1(10%) |
|
B, VA, AMX |
1(10%) |
|
AMX, B, VAN, E |
1(10%) |
|
Total |
4(40%) |
|
Salmonella spp. (n=10) |
|
|
TE, K, E |
1(10%) |
|
TE, AMX, B |
1(10%) |
|
TE, E, B, GEN |
1(10%) |
|
V, K, B, AMX |
1(10%) |
|
TE, B, K, E, GEN |
1(10%) |
|
Total |
5(50%) |
|
Pseudomonas spp. (7) |
|
|
GEN, CIP, K |
1(14.28%) |
|
GEN, V, TE |
1(14.28%) |
|
TE, CIP, V |
1(14.28%) |
|
CIP, K, TE, GEN |
1(14.28%) |
|
Total |
4(57.14%) |
MDR: Multidrug-resistant; E. coli: Escherichia coli; E: Erythromycin; B: Bacitracin; VA: Vancomycin; Met: Methicillin; AMX: Amoxicillin; TE: Tetracycline; K: Kanamycin; GEN: Gentamycin; CIP: Ciprofloxacin.